Indrayani Biotech Ltd Stock Price Today (NSE: INDRANIB)

Indrayani Biotech Ltd

9.11+0.16 (+1.79%)
Market Closed

Fundamental Score

...

Indrayani Biotech Ltd Share Price — Live NSE/BSE Price, Fundamentals & Analysis

Indrayani Biotech Ltd share price today is 9.11, up +1.79% on NSE/BSE as of 22 September 2026. Indrayani Biotech Ltd (INDRANIB) is a Small-cap company in the Other Agricultural Products sector with a market capitalisation of 41.48 (Cr). The 52-week high for INDRANIB share price is 16.47 and the 52-week low is 6.10. At a P/E ratio of 59.26x, INDRANIB is currently trading above its industry average P/E of 19.03x. The company has a Return on Equity (ROE) of 0.96% and a debt-to-equity ratio of 1.76.

Indrayani Biotech Ltd Share Price Chart — NSE/BSE Historical Performance

No data
High
9.11
Low
6.90
Volume
47.4K
Change
-5.36%

Indrayani Biotech Ltd share price chart: -5.36% return over the past month. 52-week high ₹16.47, 52-week low ₹6.10.

Indrayani Biotech Ltd — Last 10 Trading Days

DateOpenHighLowCloseVolume
9.309.368.908.951.15L (Cr)
10.1010.109.309.3675.70K (Cr)
10.7010.789.709.781.20L (Cr)
11.1011.1910.3710.8349.90K (Cr)
11.0011.2910.0010.911.92L (Cr)
10.4610.959.7510.284.10L (Cr)
9.129.749.129.743.18L (Cr)
8.408.708.008.1239.98K (Cr)
8.438.758.158.3840.77K (Cr)
8.508.648.058.2331.73K (Cr)

Indrayani Biotech Ltd — Last 12 Months Price History

MonthOpenHighLowCloseChange
7.8111.297.408.95+14.60%
7.188.956.907.98+11.14%
9.009.177.207.49-16.78%
11.1012.398.859.00-18.92%
11.9011.9310.0510.58-11.09%
7.2012.907.0911.70+62.50%
8.009.196.107.23-9.62%
9.509.707.738.08-14.95%
11.6911.998.569.58-18.05%
14.5115.1510.8511.31-22.05%
14.9016.4713.5514.73-1.14%
12.6116.4710.8014.12+11.97%

Returns & Performance

Poor

Return on Equity (ROE)

0.96%

Profit generated per ₹1 of shareholder equity

Poor

Return on Capital (ROCE)

6.08%

Returns generated on total capital deployed

Poor

Oper. Profit Margin (5Y Avg)

9.11%

Average operating profit margin over 5 years

Dividend Yield

0.00%

Annual dividend as % of current share price

Indrayani Biotech Ltd Valuation Check

Poor

Price to Earnings (P/E)

59.26x

Share price ÷ earnings per share. Lower = cheaper

Poor

Industry Avg P/E

19.03x

Average P/E of all peers in this sector

Market-cap Classification
Small-cap
Higher growth potential with higher volatility.

Shareholding Pattern

Excellent

Promoter Holding

33.26%

% shares held by company founders/management

Poor

FII Holding

0.00%

% shares held by foreign institutional investors

Poor

DII Holding

3.13%

% held by domestic mutual funds, LIC, banks

Poor

Promoter Pledged %

24.56%

% of promoter shares pledged as collateral — lower is safer

Growth Engine

Excellent

Profit Growth (Quarterly YoY)

51.33%

Net profit growth vs same quarter last year

Poor

Revenue Growth (Quarterly YoY)

-91.93%

Revenue growth vs same quarter last year

Excellent

Revenue Growth (5-Year CAGR)

21.17%

Compounded annual revenue growth over 5 years

EPS Growth (5-Year CAGR)

N/A

Earnings per share growth over 5 years

Net Profit Growth (5-Year CAGR)

N/A

Compounded annual net profit growth over 5 years

Balance Sheet Health

Poor

Debt to Equity Ratio

1.76x

Total debt ÷ equity. Below 0.5 = financially healthy

Poor

Interest Coverage Ratio

1.03x

EBIT ÷ interest expense. Above 2.5 = can pay interest comfortably

Free Cash Flow (5-Year Total)

-77.35 (Cr)

Cash left after capex over 5 years. Positive = self-funded growth

Labels (e.g., "Excellent", "Good") are peer-based vs industry/sector averages — data-only, not advice

Indrayani Biotech Ltd Fundamental Analysis & Valuation Benchmarking

Educational evaluation of INDRANIB across key market metrics for learning purposes.

Positive Indicators

3 factors identified

Robust Profit Growth (51.33%)

Observation: Strong year-over-year profit expansion demonstrates business momentum.

Analysis: Profit growth >20% indicates effective execution and market opportunity capture.

Consistent Growth Track Record (21.17% CAGR)

Observation: Strong 5-year sales compound annual growth rate.

Analysis: Consistent sales CAGR >12% demonstrates sustainable growth model.

Healthy Liquidity Position (Current Ratio: 1.74)

Observation: Strong short-term liquidity to meet obligations.

Analysis: Current ratio >1.5 indicates good working capital management.

Risk Factors

10 factors identified

Below-Average Return on Equity (0.96%)

Observation: Returns on equity are below industry benchmarks.

Analysis: ROE <10% may indicate inefficient capital utilization. Consider monitoring for operational improvements and management effectiveness.

Suboptimal ROCE (6.08%)

Observation: Returns on capital employed are below expectations.

Analysis: ROCE <10% suggests potential inefficiencies in capital allocation.

Premium Valuation Risk (P/E: 59.26x)

Observation: High valuation multiples may limit upside potential.

Analysis: Elevated P/E ratios require strong growth execution to justify current valuations.

Revenue Contraction (-91.93%)

Observation: Sales decline may indicate market challenges or competitive pressures.

Analysis: Negative revenue growth requires analysis of market conditions.

Elevated Debt Levels (D/E: 1.76)

Observation: High leverage increases financial risk and interest burden.

Analysis: High debt-to-equity ratios require monitoring of debt servicing capability.

Weak Interest Coverage (1.03x)

Observation: Limited ability to service debt obligations from earnings.

Analysis: Low interest coverage raises concerns about financial stability.

Negative Free Cash Flow (₹-77.35 Cr over 5Y)

Observation: Cash outflows exceed inflows.

Analysis: Negative FCF requires analysis of capital expenditure cycle.

Limited Institutional Interest (FII+DII: 3.13%)

Observation: Low institutional participation may affect liquidity.

Analysis: Limited institutional interest may indicate size constraints or visibility issues.

High Share Pledging Risk (24.56%)

Observation: Significant promoter share pledging creates potential overhang.

Analysis: High pledging levels may create selling pressure during market downturns.

No Dividend Distribution

Observation: Company does not currently pay dividends to shareholders.

Analysis: Zero dividend yield may indicate growth reinvestment focus or cash flow constraints.

Indrayani Biotech Ltd vs Other Agricultural Products Peers

Peer Comparison - Other Agricultural Products

Compare Indrayani Biotech Ltd with 10 other companies in the same sector

11 companies
Company Info
Fundamental
Valuation
Profitability
Financial Health
Growth
Dividend
Company
Company name
Score
Bull Run comprehensive fundamental score based on 20+ metrics
Price
Current trading price of the stock
Market Cap
Total value of all shares in the market
P/E
Price per share divided by earnings per share
ROE
Net income divided by shareholder equity
ROCE
Earnings before interest and tax divided by capital employed
Debt/Eq
Total debt divided by total equity
Profit 5Y
Average annual profit growth over 5 years
Sales 5Y
Average annual sales growth over 5 years
Dividend
Annual dividend per share divided by price per share
0/100
9
₹41.48
59.3
Average
0.96%
Poor
6.08%
Poor
1.8
Average
21.17%
Excellent
0.00%
59.6/100
454
₹15749.66
24.6
Average
0.00%
Poor
20.11%
Excellent
0.2
Excellent
17.99%
Excellent
18.70%
Excellent
0.78%
45.2/100
434
₹9944.56
13.1
Average
11.73%
Average
15.54%
Good
0.0
Excellent
2.95%
Average
8.84%
Good
0.97%
45.1/100
166
₹7632.31
18.3
Average
9.66%
Poor
13.10%
Average
0.1
Excellent
-2.08%
Poor
4.01%
Average
0.17%
51.8/100
722
₹3714.15
15.0
Average
18.17%
Good
18.21%
Good
0.0
Excellent
-0.96%
Poor
6.12%
Good
0.59%
39.7/100
109
₹2182.52
45.4
Average
5.09%
Poor
5.51%
Poor
0.0
Excellent
19.99%
Excellent
19.85%
Excellent
0.00%
40.4/100
88
₹1826.35
13.9
Average
14.47%
Average
23.69%
Excellent
0.6
Good
10.46%
Good
18.11%
Excellent
0.00%
54.6/100
305
₹1517.64
12.1
Average
14.61%
Average
19.04%
Good
0.1
Excellent
6.96%
Good
11.07%
Good
0.89%
58.2/100
92
₹1407.41
16.8
Average
0.00%
Poor
16.93%
Good
0.2
Excellent
7.57%
Good
8.01%
Good
1.13%
58.1/100
180
₹1121.80
7.6
Average
16.09%
Good
21.93%
Excellent
0.4
Excellent
11.40%
Good
24.73%
Excellent
0.17%
53.4/100
89
₹938.35
32.4
Average
22.68%
Excellent
29.10%
Excellent
0.8
Good
35.75%
Excellent
14.96%
Good
0.00%

Indrayani Biotech Ltd PE Ratio History

Historical price-to-earnings ratio for INDRANIB — last 5 years

YearEPS (₹)Price (₹)P/E Ratio
FY 20241.40₹36.2425.9x

P/E = year-end price ÷ diluted EPS from annual filings. Source: NSE/BSE via Bull Run.

Indrayani Biotech Ltd Quarterly Performance

Latest quarterly metrics for INDRANIB — revenue growth and profit growth vs same quarter last year

Revenue Growth (YoY)

-91.93%

Latest quarter vs same quarter previous year

Net Profit Growth (YoY)

51.33%

Latest quarter net profit vs same quarter previous year

5-Year Revenue CAGR

21.17%

Compounded annual revenue growth over 5 years

5-Year Profit CAGR

N/A

Compounded annual net profit growth over 5 years

Indrayani Biotech Ltd Technical Indicators

SMA 50, SMA 200, RSI and volume signals for INDRANIB — calculated from daily price history

61RSI 14
Neutral — RSI 61

Momentum is balanced — neither overbought nor oversold.

SMA 50
8
▲ Price above SMA 50 — Short-term bullish
SMA 200
10
▼ Price below SMA 200 — Long-term downtrend
30-Day Avg Volume
52K shares/day
Average daily traded volume over last 30 trading sessions

Technical indicators are for educational purposes only. Not investment advice.

Indrayani Biotech Ltd Financial Statements

Annual income statement, balance sheet and cash flow for Indrayani Biotech Ltd (INDRANIB) — sourced from NSE/BSE filings.

Financial Results & Statements

Latest quarterly, annual and period-wise financial data for Indrayani Biotech Ltd

Loading latest quarterly results...

About INDRANIB (Indrayani Biotech Ltd)

Indrayani Biotech Ltd is a pioneering force in the realm of agricultural innovation, focusing on the development and distribution of specialized products designed to enhance crop y...ields and promote sustainable farming practices. With a commitment to harnessing the power of biotechnology, the company cultivates solutions tailored to address the evolving needs of modern agriculture. Their core focus lies in creating advanced bio-stimulants, organic fertilizers, and specialized soil amendments, all rigorously tested and formulated to optimize plant health, improve nutrient uptake, and enhance resistance to environmental stresses. Indrayani Biotech strives to empower farmers with the tools necessary to cultivate thriving, resilient crops while minimizing the environmental impact of agricultural practices. The company's product portfolio extends beyond conventional agricultural inputs, encompassing a range of cutting-edge solutions for crop protection and enhancement. Indrayani Biotech is dedicated to developing and manufacturing innovative bio-pesticides and bio-fungicides, providing effective and environmentally responsible alternatives to traditional chemical treatments. These products are designed to target specific pests and diseases while preserving beneficial insect populations and minimizing the risk of soil contamination. Furthermore, the company invests in research and development to explore new avenues for improving crop resilience, including the development of drought-tolerant varieties and bio-fortified crops that offer enhanced nutritional value. Indrayani Biotech operates with a deep-seated commitment to sustainability and ethical sourcing, ensuring that its products are manufactured with minimal environmental impact and that its practices align with the principles of responsible agriculture. The company actively collaborates with farmers and agricultural experts to develop customized solutions tailored to specific regional needs and environmental conditions. Through comprehensive training programs and educational initiatives, Indrayani Biotech empowers farmers with the knowledge and resources necessary to implement sustainable farming practices and maximize the benefits of its innovative products. With a vision for a healthier, more sustainable future, Indrayani Biotech is dedicated to transforming the agricultural landscape through the power of biotechnology.

Company Details

Symbol:INDRANIB
Industry:Other Agricultural Products
Sector:Other Agricultural Products

Key Leadership

Mr. Kasiraman Sayee Sundar
MD & Executive Director
Mr. Singarababu Indirakumar
Whole Time Director
Mr. Govindarajan Swaminathan
Whole-Time Director

INDRANIB Share Price: Frequently Asked Questions

What is the current share price of Indrayani Biotech Ltd?

Indrayani Biotech Ltd (INDRANIB) trades at ₹9.11 on NSE and BSE. Market cap ₹41.48 (Cr). Educational data only.

What is the P/E ratio of Indrayani Biotech Ltd?

Indrayani Biotech Ltd has a P/E of 59.26x vs industry average 19.03x.

What is the Bull Run score for Indrayani Biotech Ltd?

Indrayani Biotech Ltd has a Bull Run score of 0/100 based on 25+ financial parameters.

Does Indrayani Biotech Ltd pay dividends?

Indrayani Biotech Ltd has a dividend yield of 0.00%. Past dividends don't guarantee future payments.

What is the ROE of Indrayani Biotech Ltd?

Indrayani Biotech Ltd has ROE of 0.96%. Higher ROE indicates better use of shareholder equity.

What is the debt-to-equity ratio of Indrayani Biotech Ltd?

Indrayani Biotech Ltd has debt-to-equity of 1.76.

Is Indrayani Biotech Ltd a good investment?

Bull Run gives Indrayani Biotech Ltd a score of 0/100. This is not investment advice — consult a SEBI-registered advisor.